Note: Ingredients listed on restricted chemical lists
EC/CAS
200-338-0/57-55-6
Name of the chemical
1,2-propanediol
Concentration
5-20%
EC/CAS
208-764-9/541-02-6
Name of the chemical
D5
Concentration
<30%
EC/CAS
205-341-0/138-86-3
Name of the chemical
1-methyl-4-prop-1-en-2-yl-cyclohexene; dl-limonene (racemic); Dipentene (37)
Concentration
<1,5%
EC/CAS
204-116-4/115-95-7
Name of the chemical
3,7-Dimethyl octa-1,6-diene-3-yl acetate (40)
Concentration
<0,6%
EC/CAS
201-291-9/80-56-8
Name of the chemical
α-pinene
Concentration
<0,5%
EC/CAS
204-642-4/123-68-2
Name of the chemical
Allyl hexanoate
Concentration
<0,15%
General Information
Version
3.0/EN
Revision date
2023-02-22
Product name
2 Phases - Mango
Manufacturer Name
Dr. MARCUS International Sp. z o.o.
Icons in SDS
Company Information
company name
Dr. MARCUS International Sp. z o.o.
e-mail address of the competent person responsible for the Safety Data Sheet
biuro@thetaconsulting.pl
GHS Information
Signal word
WARNING
Hazard Codes
Hazard statements (CLP)
H317, H412
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture Skin Sens. 1 H317, Acute Chronic 3 H412 May cause an allergic skin reaction. Harmful to aquatic life with long lasting effects
2.2 Label elements
Hazard pictograms and signal words WARNING Hazardous components placed on the label
Contains
limonene; linalyl acetate; pin-2(3)-ene; 6,8-dimethylnon-7-enal.
Hazard statements
H317 May cause an allergic skin reaction. H412 Harmful to aquatic life with long lasting effects.
Precautionary statements
P101 If medical advice is needed, have product container or label at hand. P102 Keep out of reach of children. P273 Avoid release to the environment. P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P501 Dispose of contents/container to properly labelled waste containers according to national law.
2.3 Other hazards
The product contains decamethylcyclopentasiloxane, which meet the PBT and vPvB, criteria in accordance with Annex XIII to the REACH Regulation. The product does not contain substances included in the list established in accordance with Article 59(1) for having endocrine disrupting properties, or substances identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 (3) or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % by weight. p. 1/11 Se ction 3: Comp osition/information on ingre die nts
2.1 Classification of the substance or mixture
Skin Sens. 1 H317, Acute Chronic 3 H412 May cause an allergic skin reaction. Harmful to aquatic life with long lasting effects.
